However, several subsequent investigations, particularly the pioneering work by Dang et al. [58], have reported that cancer-associated IDH1 mutations led to an alteration in the substrate preference of the enzyme, such that the mutant enzyme exhibits a higher affinity for α-KG. The gene discussed is IDH1; the disease is cancer.